Buradasınız

Diagnostic value of C-Reactive Protein (CRP) in Pain Abdomen

Journal Name:

Publication Year:

Author Name
Abstract (2. Language): 
Background : CRP is a non-specific inflammatory marker that is used routinely in clinical practice to evaluate the severity of the disease. An analysis of CRP levels was done in patients with pain abdomen to assess the usefulness of this inflammatory marker in the management of these patients. Patients and methods: Patients presenting with pain abdomen were included. Routine blood investigations including CRP and leucocyte count was done. Clinical, surgical and histopathologic data were collected. Patients were classified into those with non-specific abdominal pain (NSAP), those who were treated conservatively and those who underwent surgery and the CRP values for each of the above groups were assessed. Cut-off values (<10, 10-50, 50-100, 100-150, >150mg/l) were used to obtain a definite diagnostic value for the above groups. Results: 100 patients were selected by purposive sampling. 47 were women and 53 were men between the ages of 18-78 years. CRP was done in all patients at the time of admission. 34 patients were diagnosed to have NSAP, 32 were treated conservatively and the rest 34 required surgery. The mean values of CRP were 7mg/l for patients with NSAP, 87mg/l for those treated conservatively and 126mg/l for those who underwent surgery. Conclusion : CRP levels were statistically significant for patients with NSAP, those treated conservatively and those who underwent surgery. It increases with the severity of inflammation. Hence it can be used as a helpful marker in the management of patients with pain abdomen in addition to leucocyte count.
188
193

REFERENCES

References: 

1. Salem TA, Molloy RG, O’ Dwyer PJ. Prospective Study on the Role of C-Reactive Protein (CRP)
in Patients with an Acute Abdomen. Ann R CollSurg Engl. Apr 2007; 89(3): 233-237.
2. Thompson D, Pepys MB, Wood SP. The physiological structure of human C-reactive protein and
its complex with phosphocholine. Structure. Feb 1999; 7 (2): 169–77.
3. Pepys MB, Hirschfield GM. C-reactive protein: a critical update. J. Clin. Invest. June 2003; 111
(12): 1805–12.
4. Lau DC, Dhillon B, Yan H, Szmitko PE, Verma S. Adipokines: molecular links between obesity
and atherosclerosis. Am. J. Physiol. Heart Circ. Physiol. May 2005; 288 (5): H2031–41.
5. Chi CH, Shiesh SC, Chen KW, Wu MH, Lin XZ. C-reactive protein for the evaluation of acute
abdominal pain. Am J Emerg Med. 1996;14:254–6.
192
Indian Journal of Basic and Applied Medical Research; March 2015: Vol.-4, Issue- 2, P. 188-193
191
www.ijbamr.com P ISSN: 2250-284X , E ISSN : 2250-2858
6. Morino M, Pellegrino L, Mao P. Acute Nonspecific Abdominal Pain. Ann Surg. Dec 2006;
244(6): 881-888.
7. Eriksson S, Granstrom L, Carlstrom A. The diagnostic value of repetitive preoperative analyses of
C-reactive protein and total leucocyte count in patients with suspected acute appendicitis. Scand J
Gastroenterol. 1994; 29:1145–9.
8. Kyriakidis AV, Alexandris I, Papoulia E, Athanasiou K, Perysinakis I, Pyrgioti M, Mpourganos
D. C-reactive protein: diagnostic aid in right lower quadrant abdominal pain. Annals of
Gastroenterology. 2010; 23(4):307-310.

Thank you for copying data from http://www.arastirmax.com